J&J paid Numab Therapeutics $1.25 billion upfront for the asset in 2024 based on the belief that its dual mechanism of action ...

SaveHealth reports on eczema medications, detailing various options from topical treatments to advanced therapies for ...

Please provide your email address to receive an email when new articles are posted on . Patients taking antihypertensive drugs had a higher incidence rate of eczematous dermatitis. Diuretic drugs and ...

Investigators conducted a prospective cohort study of adult and paediatric patients from the UK-Irish Atopic eczema Systemic Therapy Register (A-STAR). Analyses compared 282 patients treated with ...

Johnson & Johnson said on Friday it discontinued a mid-stage study of its ‍experimental drug to treat patients with moderate ...

Spa treatment. Image by IQP - CC BY-SA 3.0, Spa treatment. Image by IQP - CC BY-SA 3.0, Atopic dermatitis (AD) is experiencing a shift in treatment management with recent drug approvals that address ...

Connect Biopharma Holdings Limited announced that its collaborator, Simcere Pharmaceutical Co., Ltd., has submitted a New Drug Application for rademikibart, a treatment for atopic dermatitis in adults ...

Experts discuss the recent FDA approval of topical JAK inhibitors for children 2 years or older as a promising advancement in pediatric atopic dermatitis treatment, highlighting their efficacy, their ...

Spongiotic dermatitis is a term that refers to a specific type of skin inflammation. It affects the top layer of the skin (the epidermis), leading to fluid buildup and symptoms such as scaling, ...

The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...

It’s been said before and it’s true: a healthy scalp is key to healthy hair. But for those dealing with pesky and sometimes painful scalp conditions like seborrheic dermatitis, that can be easier said ...

The number of systemic anti-inflammatory therapies for dermatologic diseases in children is expected to grow in 2026.